Jul 27, 2021 11:21 AM
BACK TO TOP
KSE100
47,863.46
190.78
(0.40%)
ALLSHR
32,686.64
108.18
(0.33%)
KSE30
19,175.47
68.60
(0.36%)
KMI30
77,477.75
204.36
(0.26%)
BKTi
12,761.85
74.33
(0.59%)
OGTi
12,394.42
91.68
(0.75%)
KMIALLSHR
23,427.44
84.76
(0.36%)
UPP9
13,307.74
23.63
(0.18%)
NITPGI
9,807.29
30.99
(0.32%)
NBPPGI
11,866.31
34.52
(0.29%)
MZNPI
11,258.84
7.56
(0.07%)
Highnoon Laboratories Limited
PHARMACEUTICALS
Rs.582.63
-5.87
(-1.00%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Mon, Jul 26, 2021 3:39 PM
REG
FUT
ODL
Open
588.00
High
589.00
Low
582.00
Volume
4,200
CIRCUIT BREAKER
538.93 — 626.33
DAY RANGE
582.00 — 589.00
52-WEEK RANGE
570.00 — 700.00
Ask Price
586.99
Ask Volume
50
Bid Price
583.00
Bid Volume
50
LDCP
582.63
VAR
12.00
HAIRCUT
22.50
P/E Ratio (TTM) **
13.08
1-Year Change *
-1.25%
YTD Change *
-2.86%
Open
571.10
High
571.10
Low
571.10
Close
571.10
Change
-1.98%
LDCP
582.63
Volume
33
Total Trades
1
CIRCUIT BREAKER
524.37 — 640.89
DAY RANGE
571.10 — 571.10
Ask Price
599.90
Ask Volume
4
Bid Price
572.03
Bid Volume
5
Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Highnoon Laboratories Limited was incorporated in Pakistan under the Companies Act, 2017. The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and allied consumer products.

KEY PEOPLE
Dr. Adeel Abbas HaideriCEO
Mr. Tausif Ahmad KhanChairman
Mr. Khadim Hussain MirzaCompany Secretary
ADDRESS

17.5 Kilometer Multan Road, Lahore.

WEBSITE

www.highnoon-labs.com

REGISTRAR

Corplink (Pvt) Ltd. Wings Arcade 1 K Commercial, Model Town, Lahore.

AUDITOR

EY Ford Rhodes Chartered Accountants.

Fiscal Year End

December

Equity Profile

Market Cap (000's)
22,184,476.82
Shares
38,076,441
Free Float
17,134,398
Free Float
45.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 29, 2021Transmission of Quarterly Report for the Period Ended 31 March 2021 View   PDF
Apr 29, 2021Financial Results for the Quarter Ended March 31, 2021 View   PDF
Mar 25, 2021Financial Results For The Year Ended 31 December 2020 View   PDF
Oct 28, 2020TRANSMISSION OF QUARTERLY REPORT FOR THE PERIOD ENDED 30 SEPTEMBER 2020 View   PDF
Oct 26, 2020Financial Results for the Quarter Ended September 30, 2020 View   PDF
Aug 28, 2020TRANSMISSION OF QUARTERLY REPORT FOR THE PERIOD ENDED 30 JUNE 2020 View   PDF
Aug 24, 2020FINANCIAL RESULTS FOR THE HALF YEAR ENDED 30 JUNE 2020 View   PDF
Apr 30, 2020TRANSMISSION OF QUARTERLY REPORT FOR THE 1ST QUARTER ENDED 31 MARCH 2020 View   PDF
Apr 30, 2020FINANCIAL RESULTS FOR THE 1ST QUARTER ENDED 31 MARCH 2020 View   PDF
Apr 21, 2020ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2019 View   PDF
DateTitleDocument
Apr 21, 2021Board Meeting View   PDF
Apr 6, 2021Notice of Annual General Meeting View   PDF
Mar 18, 2021Board Meeting View   PDF
Oct 20, 2020Board Meeting View   PDF
Aug 17, 2020Board Meeting View   
Apr 22, 2020BOARD MEETING View   PDF
Apr 21, 2020NOTICE OF ANNUAL GENERAL MEETING View   PDF
Mar 31, 2020Annual General Meeting View   PDF
Mar 25, 2020Board Meeting View   PDF
Oct 21, 2019Board Meeting View   PDF
DateTitleDocument
Jul 19, 2021Fixation of Number of Directors View   PDF
May 24, 2021Credit/Dispatch of Bonus Shares Certificates View   
May 21, 2021Shareholders Resolutions passed in 38th AGM of the Company View   PDF
May 21, 2021Shareholders Resolutions passed in 38th AGM of the Company View   PDF
May 20, 2021Final Cash Dividend FY 2020 View   
Apr 21, 2021CORPORATE BRIEFING SESSION-HIGHNOON LABORATORIES LIMITED View   PDF
Apr 7, 2021Transmission of Annual Report for FYE 31 December 2020 (Single Combined File) View   PDF
Apr 6, 2021Transmission of Annual Report FYE 31 December 2020 View   PDF
Apr 6, 2021Transmission of Annual Report FYE 31 December 2020 View   PDF
Mar 25, 2021Issue of Bonus Shares View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2020201920182017
Sales10,697,6349,047,6937,503,1015,971,229
Profit after Taxation1,420,736971,013725,891626,465
EPS41.0428.0523.0724.53
Q1 2021Q3 2020Q2 2020Q1 2020
Sales3,117,0862,842,3622,491,2642,565,606
Profit after Taxation409,024326,281364,084287,562
EPS11.829.4310.528.31
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2020201920182017
Gross Profit Margin (%)47.8746.0046.6547.66
Net Profit Margin (%)13.2810.739.6710.49
EPS Growth (%)46.3121.59(5.95)17.14
PEG0.320.89(2.53)1.02

Payouts

DateFinancial ResultsDetailsBook Closure
March 25, 2021 4:01 PM31/12/2020(YR) 150%(F) (D) - 10% (B) 26/04/2021 - 27/04/2021
March 31, 2020 3:12 PM31/12/2019(YR) 130% (D) - 10% (B) 05/05/2020 - 12/05/2020
March 29, 2019 4:20 PM31/12/2018(YR) 130%(F) (D) - 10% (B) 23/04/2019 - 29/04/2019
March 9, 2018 3:55 PM31/12/2017(YR) 100% (D) - 12% (B) 12/04/2018 - 23/04/2018
March 16, 2017 3:45 PM31/12/2016(YR) 85% (D) - 12% (B) 21/04/2017 - 27/04/2017
March 15, 2016 3:38 PM31/12/2015(YR) 75% (D) - 12% (B) 14/04/2016 - 22/04/2016
March 20, 2015 3:49 PM31/12/2014(YR) 65% (D) - 12% (B) 17/04/2015 - 27/04/2015
March 18, 2014 2:49 PM31/12/2013(YR) 45% (D) 15/04/2014 - 24/04/2014
March 19, 2013 1:12 PM31/12/2012(YR) 35% (F) (D) 15/04/2013 - 23/04/2013
March 22, 2012 1:32 PM31/12/2011(YR) 30%(F) (D) 24/04/2012 - 30/04/2012

Financial Reports